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ttps://doi.org/10.1016/j.ajpath.2020.07.015Immune aggregates organized as tertiary lymphoid structures (TLS) are observed within the kidneys of
patients with systemic lupus erythematosus and lupus nephritis (LN). Renal TLS was characterized in
lupus-prone New Zealand black  New Zealand white F1 mice analyzing cell composition and vessel
formation. RNA sequencing was performed on transcriptomes isolated from lymph nodes, macro-
dissected TLS from kidneys, and total kidneys of mice at different disease stages by using a personal
genome machine and RNA sequencing. Formation of TLS was found in antiedouble-stranded DNA
antibodyepositive mice, and the structures were organized as interconnected large networks with
distinct T/B cell zones with adjacent dendritic cells, macrophages, plasma cells, high endothelial ve-
nules, supporting follicular dendritic cells network, and functional germinal centers. Comparison of
gene profiles of whole kidney, renal TLS, and lymph nodes revealed a similar gene signature of TLS and
lymph nodes. The up-regulated genes within the kidneys of lupus-prone mice during LN development
reflected TLS formation, whereas the down-regulated genes were involved in metabolic processes of the
kidney cells. A comparison with human LN gene expression revealed similar up-regulated genes
as observed during the development of murine LN and TLS. In conclusion, kidney TLS have a similar cell
composition, structure, and gene signature as lymph nodes and therefore may function as a
kidney-specific type of lymph node. (Am J Pathol 2020, 190: 2203e2225; https://doi.org/10.1016/
j.ajpath.2020.07.015)Supported by Northern Norway Regional Health Authority research
grants HNF1375-17 (K.A.F.), SFP1263-15 (K.A.F.), HNF1343-17
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Disclosures: None declared.Systemic lupus erythematosus (SLE) and lupus nephritis
(LN) are chronic autoimmune diseases characterized by
inflammation and damage in the kidneys.1,2 The deposition
of immune complexes within the glomeruli and within the
tubular interstitial membranes stimulates glomerular and
tubular cells to produce chemokines that attract immune
cells and can also activate intrinsic immune cells, such as
macrophages and dendritic cells (DCs).3e7 This deposition
led to an increased accumulation of immune cells within the
kidneys during the development of LN.8
Chronic inflammatory processes, such as infection and
autoimmunity, cause tertiary lymphoid structures (TLS) to
develop within different organs.9 These structures, resem-
bling secondary lymphoid organs,10 have been detected instigative Pathology. Published by Elsevier Inc
Y license (http://creativecommons.org/licensespatients with different diseases that affect the kidneys, such
as IgA nephropathies11 and LN,12,13 and in calcineurin Aa
heterozygous mice,14 lupus-prone mice,15 and during
aging.16,17 The size and location of kidney biopsies make it
difficult to assess the extent of the developed TLS in human
LN. Whether TLS are sites for activation or inhibition of
immune cells is still not known.15.
/by/4.0).
Dorraji et alChanges in gene expression during the development of
LN have been extensively studied in human and murine
LN.18e20 Most of the differences in gene expression
observed in diseased LN kidneys compared with healthy
kidneys are involved in the activation of the innate and
the adaptive immune systems.21 This finding indicates
that the formation of TLS might be an important feature
of LN. In a longitudinal study on lupus-prone, New
Zealand black  New Zealand white (NZB/W) F1 mice,
the formation of renal immune aggregates resembling
TLS during the progression of LN has been observed.22
We hypothesize that the gene profile of kidney-specific
TLS is similar to the lymph nodes of lupus-prone mice
in an active stage of disease. The present study was un-
dertaken to characterize the cell composition and analyze
the gene expression profile of macrodissected kidney-
specific TLS compared with whole kidney and lymph
nodes of lupus-prone mice during the development of
antiedouble-stranded DNA (dsDNA) antibody productionTable 1 Mice Used in This Study





1 7 0 0
2 7 0 0
3 7 0 0
4 7 0 0
5 7 0 0
6 35 5 4
7 35 7 0
8 29 4 0
9 28 4 0
10 28 4 0
11 29 4 0
12 20 7 0
13 36 4 0
14 36 4 0
15 26 5 0
16 37 13 4
17 36 9 4
18 36 11 4
19 30 5 4
20 41 14 2
21 30 Negative 4
22 38 8 4
23 41 6 2
24 41 13 2
25 39 13 4
26 28 9 4
27 36 10 4
28 36 13 4
29 28 5 4
30 37 11 4
Bold indicates selected for RNA sequencing.
ACR, albumin/creatinine ratio (normal, 0 to <30; microalbuminuria, 30 to 3
structures.




NZB/W mice were obtained from Jackson Laboratory (Bar
Harbor, ME). Treatment and care of animals were con-
ducted in accordance with guidelines of the Norwegian
Ethical and Welfare Board for Animal Research, and the
institutional review board approved the study.
Isolation of Lymph Nodes and Kidneys from NZB/W
Mice
Seven-weekeold NZB/W mice (Table1) (n Z 5), 20- to 41-
weekeold mice 4 to 14 weeks anti-dsDNAepositive (n Z
12), and 28- to 39-weekeold nephritic mice 5 to 13 weeksACR
Histology Score
(range, 0e4) TLS test result
RNA
Sequencing
12 2 Negative M1
4 2 Negative M2
32 2 Negative M3
28 2 Negative M4
42 2 Negative M5
2729 4 Positive NP
2 2 Positive NP
2 2 Positive M6
NP 2 Positive M7
8 3 Positive M8
61 3 Positive M9
61 2 Positive NP
226 3 Positive NP
108 3 Positive NP
7 2 Positive M10
NP NP Positive NP
NP 4 Positive NP
NP NP Positive NP
NP 4 Positive NP
NP 2 Positive NP
NP 3 Positive NP
NP NP Positive NP
NP NP Positive NP
NP NP Positive NP
NP 4 Positive M11
NP NP Positive NP
NP 4 Positive M12
NP 3 Positive M13
NP 4 Positive M14
NP 4 Positive M15
00; clinical proteinuria, >300); NP, not performed; TLS, tertiary lymphoid













































Figure 1 All mice with antiedouble-
stranded DNA (dsDNA) antibody production
for 4 to 5 weeks had large tertiary lymphoid
structures (TLS) within the pelvic area con-
nected to the biggest veins and arteries. A:
The anti-dsDNA antibody production in sera
was followed by an in-house enzyme-linked
immunosorbent assay. The absorbance was
measured at OD 492, and antibody titer was
calculated based on 40% of the positive
control. The figure shows the results of the
mice later selected for deep sequencing
(M6-M15) (Table 1). Asterisks indicate
proteinuric mice (group 3). B and F: Trans-
verse sections of kidneys revealed large TLS
(black arrows) in connection to the pelvic
wall and close to the biggest veins and ar-
teries. C and D: Longitudinal sections pre-
sent several areas with immune aggregates
organized as TLS. C and E: TLS (black ar-
rows) are also detected in the perirenal fat
(black arrowheads) and in the cortex of
proteinuric mice (white arrowheads). G: A
kidney from a proteinuric mouse divided
into three parts was serial sectioned and
stained with eosin. The TLS, largest veins,
and largest arteries were depicted in ImageJ
software version 1.52 and assembled as a
three-dimensional structure. The sections
from the kidney were highlighted for TLS
(yellow), arteries (red), and veins (blue),
and the layers were merged into three fig-
ures depicting the upper, middle, and lower
parts of the kidney. Stippled squares in
panel F depict area of interest in Figure 2A.
The images are representative of group 2
and group 3 mice. Scale bars: 1000 (BeE);
500 mm (F). Original magnification, 4 (G).
a, artery; h, hilum; m, medulla; prf, peri-
renal fat; pw, pelvic wall; us, urinary space;
v, vein.
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Interconnected TLS in Lupus Nephritisanti-dsDNA positive (n Z 13) were sacrificed as described
previously.3 The kidneys and renal lymph nodes were iso-
lated and processed for RNA isolation immunohistochem-
istry analysis as described.5
Determination of Proteinuria, Anti-dsDNA Antibodies
by Enzyme-Linked Immunosorbent Assay, and
Histologic Classification of Lupus Nephritis
Urine samples were tested every week until the onset of
proteinuria. Full-blown LN was defined when proteinuria
reached 4þ, as determined by Urine Stix (Bayer Di-
agnostics, Bridgend, UK): 0 to 1þ was defined as <1 g/L
(physiologic proteinuria); 2þ, 1 to 3 g/L; 3þ, 3 to 20 g/
L; and 4þ, 20 g/L. End point urine were collected if
possible and analyzed using the albumin/creatinine ratio
(ACR) assay kit from PromoKine (Heidelberg, Germany).
ACR results were defined as follows: normal, 0 to <30;
microalbuminuria, 30 to 300; and clinical proteinuria,
>300. However, chronic kidney disease may be present if
ACR 30. Blood samples were taken every week until anti-
dsDNA positivity was detected; thereafter, samples were
taken every second week until proteinuria was detected.
Serum samples were collected and stored at 20C until
use. Serum antibodies against dsDNA were determined
by enzyme-linked immunosorbent assay as previously
described.23,24 Sera were diluted twofold from 1/100 to 1/
6400 in phosphate-buffered saline (PBS) (0.02% Tween),
and the positive control 163c3 anti-dsDNA monoclonal
antibody (kindly provided by T.N. Marion, The University
of Tennessee Health Science Center, Memphis, TN25) was
included in each enzyme-linked immunosorbent assay for
assay validation and determination of cut-off value. The
optical density cut-off values were set to >0.2 at A493, and
positive titers were determined when 40% of positive con-
trol mAbs was reached. Classification of kidney damage
was analyzed based on the 2019 European League Against
Rheumatism and the American College of Rheumatology
criteria.26 Pathologic findings were scored by observers
who were blinded to the genotype. Paraffin-embedded
sections 4 mm thick were dewaxed and stained withFigure 2 T cells and B cells are prominent cells of tertiary lymphoid structu
network of blood and lymph vessels. A: Immunohistochemistry performed with a
follicular dendritic cells (FDCs), double staining B220 (purple) and CD21 (brown),
(PNAD) (MECA-79) detecting high endothelial venules (HEVs), antiemonoclonal
antieB-cell lymphoma 6 (BCL6) detecting germinal center B and T cells. B: Imm
regulatory T cells and anti-B220 detecting B cells. C: Immunofluorescence perf
stomach expression (Mist)-1 detecting plasma cells. D: CD31 staining detecting
cells in larger vessels (white arrowheads) and microcapillaries or thicker cells
asterisks), and some of the thin vessels are lymphatic vessel endothelial hyaluro
filled with leukocytes that were mostly CD3-positive T cells and B220-positive B
vessels were F4/80 or CD21-positive macrophages and FDCs, respectively. F: In y
F480-positive macrophages could be detected within the pelvic wall. Scale bars:
and D, right columns); 50 mm (C). Original magnification:10 (A, left column);
v, vein.
The American Journal of Pathology - ajp.amjpathol.orghematoxylin and eosin. The sections were scanned using a
VS120 virtual slide microscope (Olympus, Asker, Norway).
Each kidney was examined at 400 magnification and
scored from 0 to 4 based on the following features:
glomerular size and hypercellularity, changes in glomerular
matrix, and the degree of hypercellularity in the
tubulointerstitium.
Immunohistochemistry
Immunohistochemistry using Polink-2 Plus HRP detec-
tion kits for tissue (anti-rabbit and anti-rat) (Golden
Bridge International Inc., Mukilteo, WA) was performed
on Zink- or 4% paraformaldehyde-fixed kidneys
embedded in paraffin. Anti-mouse CD3 was obtained
from Dako (Glostrup, Denmark). Anti-mouse CD45R
(B220) was purchased from R&D Systems (Minneapolis,
MN). Antibodies against mouse B-cell lymphoma 6
(BCL6), CD21, and lymphotoxin b-receptor (LTBr) were
purchased from Abcam (Cambridge, UK). Anti-mouse
peripheral lymph node addressin (PNAD) and anti-mouse
F4/80 were obtained from BioLegend (San Diego, CA).
Anti-mouse monoclonal anti-DC antibody (MIDC)-8 was
obtained from Nordic BioSite (Oslo, Norway). Images
were collected with an Olympus microscope (BX51 and
DP74).
Immunofluorescence
Immunofluorescence staining was performed on 5-mm
kidney cryosections. The sections were dried at room
temperature for 30 minutes and then fixed for 5 minutes in
4% paraformaldehyde. Sections were washed three times in
1 PBS for 5 minutes each and incubated with blocking
serum (1 PBS with 10% donkey serum) (AB7475,
Abcam) for 30 minutes. The sections were incubated with
primary antibodies [B220 and muscle, intestine and stom-
ach expression (Mist) (BHLHA15, Biorbyt, Cambridge,
UK) or B220 and forkhead box P3 (FoxP3) (Novus Bi-
ologicals, Bio-Techne Ltd., Abingdon, UK)] for 30 minutes
and washed three times in 1 PBS for 5 minutes each. Theres (TLS) and are organized into distinct T- and B-cell areas with a large
nti-CD3 detecting T cells, anti-B220 detecting B cells, anti-CD21 detecting
anti-F4/80 detecting macrophages, antieperipheral lymph node addressin
antiedendritic cell (DC) antibody (MIDC)-8 detecting activated DCs, and
unofluorescence performed with antieforkhead box P3 (FoxP3) detecting
ormed with anti-B220 detecting B cells and antie muscle, intestine and
endothelial cells reveals a network of different vessels with positive wispy
as in HEVs (black asterisk). The HEVs stained positively for PNAD (white
nan receptor 1 positive. E: The larger thin vessels (white arrowheads) are
cells and a few MIDC-8epositive DCs. None of the immune cells within the
oung antiedouble-stranded DNAenegative mice, CD3-positive T cells and
200 mm (A, left column); 100 mm (B; D, left column, E, and F); 20 mm (A
20 (B, and D, left column);60 (A, right column, and C). G, glomerulus;
2207




Antibody Titer Proteinura ACR
Histologic
Score Ltb
Age 0.902 0.895 0.625 0.142 0.789 0.726
Weeks of anti-dsDNA
antibody
<0.001 0.796 0.646 0.302 0.788 0.775
Titer <0.001 <0.001 0.360 0.209 0.678 0.805
Proteinura 0.013 0.009 0.187 0.502 0.845 0.244
ACR 0.677 0.366 0.537 0.115 0.466 0.342
Histologic score <0.001 <0.001 0.006 <0.001 0.148 0.637
Ltb 0.002 0.001 <0.001 0.380 0.303 0.011
Ltbr 0.110 0.012 0.507 0.001 0.360 0.029 0.541
Rankl 0.025 0.034 0.001 0.805 0.852 0.247 <0.001
Ccl21a 0.239 0.043 0.238 0.380 0.004 0.099 0.025
Cxcl13 <0.001 0.001 <0.001 0.314 0.526 0.009 <0.001
Ccr7 <0.001 <0.001 <0.001 0.031 0.149 <0.001 <0.001
Aid 0.008 0.005 <0.001 0.902 0.831 0.115 <0.001
Vcam1 <0.001 <0.001 0.002 0.001 0.136 <0.001 0.002
Icam1 <0.001 <0.001 0.001 0.004 0.789 <0.001 0.001
Pou2af1 0.001 0.002 0.001 0.179 0.265 0.008 <0.001
Glycam 0.005 0.001 0.012 0.065 0.232 0.009 <0.001
(table continues)
Dorraji et alsections were incubated with secondary antibody (AF488
anti-rat IgG and AF546 anti-rabbit IgG) for 30 minutes in
the dark and were washed three times in 1 PBS for 5
minutes each. The sections were carefully dried and
mounted using 10 mL of DAPI (Invitrogen, Fisher Scien-
tific, Oslo, Norway). For each sample, a negative control
was prepared by the same procedure with an irrelevant
control antibody. Images were collected with an Olympus
microscope (BX51 and DP74).Three-Dimensional Structure of TLS with Adjacent
Arteries and Veins
Serial kidney sections (10-mm thick) from a NZB/W mouse
were stained with hematoxylin, and images were obtained at
4 magnification. The TLS, arteries, and veins were out-
lines, reconstructed, and visualized in three dimensions
using the TrakEM2 plugin in ImageJ software version 1.52
(NIH, Bethesda, MD; http://imagej.nih.gov/ij).
Total RNA Extraction from Lymph Nodes, TLS, and
Kidney Tissue
Total RNA of lymph nodes from 4- and 8-weekeold and
proteinuric mice, or immune aggregates/TLS dissected
manually under the loupe (magnification, 10) from pro-
teinuric kidney, or kidney tissue from the same kidney, were
purified by TRIzol regent (Ambion, Thermo Fisher, Oslo,
Norway) according to manufacturer’s instructions. Total
RNA of lymph nodes from anti-dsDNA antibodyepositive2208mice were isolated using miRNeasy mini kit (Qiagen, Oslo,
Norway). The concentration and quality of extracted total
RNA were assessed using the Agilent RNA 6000 nano kit
with the Agilent 2100 Bioanalyzer instrument (Agilent,
Matriks AS, Norway). All RNA used in this study had an
RNA integrity number 7.
Total RNA Extraction from Total Kidney
Total RNA samples were prepared for sequencing using the
Qiagen Allprep total RNA kit (Qiagen). Briefly, tissue
sections (20 to 30 mg) taken from the middle of the kidneys
were lyzed and homogenized in 600 mL of Buffer RLT in 2
mL of Magna Lyser green beads tubes (Roche Life Sci-
ences, Oslo, Norway) at 600  g for 30 seconds using the
Precellys 24 tissue homogenizer (Bertin Technologies, Aix-
en-Provence, France). The lysates were centrifuged at full
speed for 3 minutes, the supernatant was carefully trans-
ferred to the AllPrep spin column, and RNA isolation was
performed according to the manufacturer’s protocol. The
isolated RNA was analyzed by Agilent. Only RNA samples
of high quality (RNA integrity number 8.0) were used.
Sequencing of total kidney mRNA was performed by
Eurofins Genomics (Ebersberg, Germany) using the Illu-
mina HiSeq 2000 system.
Sequencing of Paired Lymph Nodes, TLS, and Kidneys
Library Preparation
Polyadenylated mRNA was isolated from total RNA
using Dynabeads mRNA Direct Micro Kit (Ambion,ajp.amjpathol.org - The American Journal of Pathology
Ltbr RANKL Ccl21a Cxcl13 CCR7 Aid Vcam1 Icam1 Pou2af1 Glycam
0.430 0.574 0.324 0.794 0.801 0.658 0.828 0.885 0.761 0.682
0.631 0.549 0.529 0.762 0.877 0.681 0.844 0.905 0.729 0.784
0.186 0.752 0.324 0.855 0.831 0.814 0.733 0.778 0.783 0.630
0.768 -0.070 0.244 0.279 0.558 0.035 0.768 0.713 0.367 0.489
0.306 0.064 0.790 0.215 0.466 0.073 0.479 0.098 0.368 0.393
0.562 0.318 0.442 0.651 0.826 0.425 0.908 0.893 0.653 0.647
0.171 0.875 0.575 0.914 0.814 0.893 0.736 0.780 0.903 0.829
-0.089 0.254 0.175 0.457 0.107 0.543 0.486 0.216 0.393
0.752 0.229 0.818 0.621 0.929 0.454 0.560 0.806 0.664
0.362 0.413 0.450 0.518 0.311 0.543 0.451 0.463 0.504
0.533 <0.001 0.092 0.825 0.854 0.782 0.846 0.888 0.704
0.087 0.013 0.048 <0.001 0.675 0.846 0.886 0.767 0.704
0.704 <0.001 0.260 <0.001 0.006 0.536 0.635 0.806 0.711
0.037 0.089 0.037 0.001 <0.001 0.040 0.925 0.797 0.768
0.078 0.037 0.106 <0.001 <0.001 0.015 <0.001 0.815 0.780
0.439 <0.001 0.082 <0.001 0.001 <0.001 <0.001 <0.001 0.883
0.147 0.007 0.056 0.003 0.003 0.003 0.001 0.001 <0.001
Table 2 (continued)
Interconnected TLS in Lupus NephritisThermo Fisher) followed by its fragmentation using
RNase III with mean sizes of 100 to 200 nt. The frag-
mented mRNA was cleaned and the yield and size dis-
tribution determined using the Agilent RNA 6000 Pico
kit with the Agilent 2100 Bioanalyzer instrument. After
adapter ligation at both ends of fragmented mRNA,
reverse transcription was performed, followed by PCR
amplification. After purification of amplified cDNA, the
yield and size distribution were analyzed using an Agi-
lent High Sensitivity DNS kit with Agilent 2100 Bio-
analyzer instrument.
Sequencing
All libraries were amplified with emulsion PCR (Ion One
Touch 2 instrument), and enrichment of template Ion
Sphere Particles was performed with the Ion One Touch
ES system. Quality control of Ion Sphere Particles was
performed with an Ionsphere Quality Control kit using
Qubit version 2.0 (Life Technologies, Thermo Fisher,
Oslo, Norway). The enriched Ion Sphere Particles were
sequenced using an Ion Torrent 316 chip with sequencer
Ion Torrent Personal Genome Machine (Ion Torrent
PGM) according to manufacturer’s instructions.
Bioinformatics Analysis
All sequences were imported and analyzed in CLC Geno-
mics Workbench 8 (CLCbio, Aarhus Denmark). Adaptor
sequences were trimmed, and RNA sequencing was con-
ducted using Mus_musculus GRCm 38.80 as a reference
genome by default.The American Journal of Pathology - ajp.amjpathol.orgDeep Sequencing of Whole Kidney Sections
RNA Sequencing
RNA sequencing cDNA libraries were prepared from the
total RNA isolated from kidneys of 15 NZB/W F1 mice
(Table 1). Fifteen 30-fragments with an insert size of
approximately 200 to 450 bp were prepared and sequenced
using the Illumina HiSeq 2000 version 3.0 system (Eurofins
Genomics). The samples were divided into three channels
with five libraries per channel containing 1  100-bp single-
read module. The sequences were demultiplexed according
to the 6-bp index code allowing 1 mismatch (Eurofins
Genomics).
Alignments and Assignment of Reads to Genes
Eurofins Genomics performed alignments and assignment
of reads to genes. The alignment of reads to a reference
sequence was performed using the BWA-backtrack
version 0.6.2-r126 (http://bio-bwa.sourceforge.net, last
accessed June 18, 2019). Raw read counts were created
using HTSeq with Python software version 2.7 (Python
Software Foundation, Fredericksburg, VA; https://www.
python.org). Reads with unique mapping positions were
considered for read counting. Paired-end reads that were
mapped to the same reference with approximately the
expected insert size were counted as one read. Paired-
end reads that were mapped to different references or
with an unexpected insert size were counted as two
reads. If only one read of a pair was mapped, it was
counted as one read. Only reads that overlapped exon2209
Dorraji et alfeatures were counted. All reads mapping to features with
the same identifier were summed. The gene attribute was
used as feature identifier. Reads mapping to multiple
features with different identifier were ignored for read
counting. The mean read length was 100.0 (Eurofins
Genomics).
Filtering and Normalization for Composition Bias
The CPM (counts per million) function from the edgeR
library was used to generate the CPM values; the CPM
values were further filtered. The ratio of RNA production
was estimated by using a weighted trimmed mean of log
expression ratios called the trimmed mean of M values.
The calcNormFactors function from edgeR package
calculated the normalization factors among libraries. These
normalization factors are rescaled by the mean of the
normalized library sizes. Normalized read counts were
obtained by dividing raw read counts by these rescaled
normalization factors. This was performed to eliminate
composition biases among libraries.27 A multidimensional
scaling plot was generated with the plotMDS function
from limma package. Distances between samples was
calculated with leading fold change defined as the root
mean square of the largest 500 log2 fold changes among
samples.
Differential Expression Analysis
Differential expression analysis was performed using the
edgeR package.28 Differential expression data were
filtered to contain a false discovery rate <0.05. An
empirical Bayes procedure was used to shrink the dis-
persions toward a consensus value, borrowing informa-
tion among genes. The results were tested for differential
expression using the generalized linear model likelihood
ratio test. The likelihood ratio test was performed by
estimating two groups and by comparing the fit of one
group with the fit of the other. To deal with multiple
tests, individual tests were made with separate computa-
tions to test for different contrasts. Three different con-
trasts were made to test the hypothesis that the different
coefficients in each contrast (ie, the three different
groups) were equal. The glmLRT function from edgeR
was used to conduct likelihood ratio tests for the co-
efficients in the linear model, such as the Fisher exact
test, and adapted for over dispersed data.27 The results
were corrected for multiple hypothesis testing via the
Benjamini-Hochberg procedure. For each gene, an
adjusted P value was calculated to enable the expected
proportion of positive results returned that were false-
positive results (ie, false discovery rate). Venn diagrams
were drawn to visualize the overlap between up-regulated
and down-regulated genes among all three groups using
the vennDiagram package from limma. All relevant data
have been deposited in the Gene Expression Omnibus
(https://www.ncbi.nlm.nih.gov; accession number
GSE155405).2210Statistical Analysis
GraphPad Prism software version 5.0 (GraphPad Soft-
ware, San Diego, CA) was used to perform statistical
comparison analyses. Results are expressed as
means  SEM. Statistical significance was set at
P < 0.05. Statistical significance was assessed using a
paired t-test, one-way or two-way analysis of variance,
followed by the Bonferroni posttest as indicated in the
figures. Differentially expressed (DE) genes were divided
into up-regulated and down-regulated genes, according to
an adjusted P <0.05 and logFC value 1.0/1.0, respec-
tively. Venn diagrams were drawn to visualize the over-
lapping of DE genes using the groupings from the
multidimensional scaling plot plot. Statistical significance
is indicated as follows in the figures. A Spearman’s
correlation matrix was generated based on clinical pa-
rameters and gene expression.
Results
TLS Occur Close to the Pelvic Wall, Large Arteries, and
Large Veins and Are Organized into Large
Interconnected Networks of Immune Aggregates
within the Kidneys of Lupus-Prone Mice
The production of anti-dsDNA antibody was measured
every week until antibody-positive titer and then every
second week until onset of proteinuria or until the mice
reached 4 to 5 weeks with antibody positivity (Figure 1A
and Table 1). All mice with anti-dsDNA antibody-positive
titer for 4 to 5 weeks had developed TLS near the pelvic
wall, large arteries, and large veins (Figure 1, BeE).
Some mice had TLS within the perirenal fat (Figure 1, C
and E). Smaller TLS were also detected in the cortex of
kidneys from proteinuric mice (Figure 1, C and F). To
examine the structural specifications of TLS and to
investigate whether the TLS developed in separate regions
of the kidneys, a three-dimensional structure of serial
sections of a whole kidney was made (Figure 1G). The
three-dimensional structure revealed an interconnected
large network of immune aggregates located close to or
surrounding the arteries and veins (Figure 1G). The larger
structures were found in the renal pelvic area between the
pelvic wall and the biggest veins (Figure 1G), whereas
the smaller structures were located around the arteries in
the superior and inferior sections of the kidney
(Figure 1G).
TLS Contain All Cells Needed To Be a Functional
Immunologic Site for Activation and Regulation of
Immune Cells
Most cells in TLS were CD3þ T cells with surrounding
characteristic B220þ B-cell areas (Figure 2A). The B-cell
areas contained a network of CD21þ follicular DCsajp.amjpathol.org - The American Journal of Pathology
(1977 genes)(644 genes)








































































































Up in TLS Up in LyN
LyN vs TLS
Figure 3 Gene expression in tertiary lymphoid structures (TLS) resembles lymph nodes (LyN). A: Venn diagram depicting the common and unique genes of
all differentially expressed (DE) genes in kidney versus lymph nodes, kidney versus TLS, and lymph nodes versus TLS. B: Volcano plot showing up- and down-
regulated gene expression in kidney versus lymph nodes, kidney versus TLS, and lymph nodes versus TLS comparisons. C: Venn diagram of 644 TLS genes
compared with 1977 lymph nodes genes showing 600 common genes. FC, fold change; LyN, lymph nodes, Padj, P adjusted.
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Table 3 Tertiary Lymphoid Structure Genes Found Enriched in Pathways Recognized by the Reactome Pathway Analyzer
Pathway
Entities Reactions
Found, n Total, n Ratio P FDR Found, n Total, n Ratio
CD22-mediated BCR
regulation
68 104 0.009 1.11  1016 1.59  1014 4 4 0.001
Classic antibody-mediated
complement activation
68 108 0.01 1.11  1016 1.59  1014 2 2 0
FCGR activation 70 116 0.01 1.11  1016 1.59  1014 5 5 0.001
Antigen activates BCR,
leading to generation of
second messengers
75 127 0.011 1.11  1016 1.59  1014 10 14 0.002
Creation of C4 and C2
activators
68 119 0.011 1.11  1016 1.59  1014 2 6 0.001
Initial triggering of
complement
70 128 0.012 4.44  1016 5.28  1014 8 19 0.002
FCERI mediated Caþ2
mobilization
72 135 0.012 5.55  1016 5.66  1014 5 6 0.001
Role of LAT2, NTAL, and LAB
on calcium mobilization
66 117 0.011 7.77  1016 6.92  1014 4 5 0.001
FCERI-mediated MAPK
activation
70 134 0.012 4.11  1015 3.25  1013 12 19 0.002
Role of phospholipids in
phagocytosis
70 135 0.012 5.77  1015 4.1  1013 6 9 0.001
Regulation of complement
cascade
70 141 0.013 4.46  1014 2.9  1012 5 23 0.003
Scavenging of heme from
plasma
64 125 0.011 1.45  1013 8.57  1012 1 12 0.002
Regulation of actin dynamics
for phagocytic cup
formation





90 222 0.02 9.56  1013 4.88  1011 13 26 0.003
Complement cascade 71 156 0.014 1.6  1012 7.52  1011 15 50 0.006
Signaling by the BCR 84 209 0.019 8.4  1012 3.7  1010 23 28 0.004
FCGR-dependent phagocytosis 73 172 0.016 1.82  1011 7.66  1010 17 25 0.003
Binding and uptake of ligands
by scavenger receptors
65 168 0.015 7.84  109 3.06  107 2 22 0.003
FCERI-mediated NF-kB
activation
68 181 0.016 1.09  108 4.05  107 14 17 0.002
Cell surface interactions at
the vascular wall
79 228 0.021 2.22  108 7.78  107 18 58 0.007
FCERI signaling 78 235 0.021 1.49  107 5.05  106 40 52 0.007
PD-1 signaling 16 26 0.002 2.28  105 7.31  104 4 4 0.001
Generation of second
messenger molecules
17 32 0.003 7.74  105 2.31  103 13 14 0.002
Translocation of ZAP-70 to
immunological synapse
14 23 0.002 8.09  105 2.31  103 4 4 0.001
Phosphorylation of CD3 and
TCR z chains
15 26 0.002 8.24  105 2.31  103 7 7 0.001
Data from https://reactome.org, last accessed June 25, 2020.
BCR, B-cell receptor; FCERI, Fcε receptor; FCGR, Fcg receptor; FDR, false discovery rate; LAB, linker for activation of B cells; LAT2, linker for activation of T cells 2; MAPK,
mitogen-activated protein kinase; NTAL, noneT-cell activation linker; PD-1, programmed death 1; TCR, T-cell receptor; ZAP-70, z chaineassociated protein kinase 70.
Dorraji et al(FDCs) (Figure 2A), and the T-cell areas were rich in
activated MIDC-8þ DCs (Figure 2A8) and a few FoxP3þ
cells (Figure 2B). F4/80þ macrophages were detected
within the pelvic wall, in the TLS close to the kidney2212tissue or perirenal fat, and interspersed within the structure
(Figure 2A). PNAD and high endothelial venules (HEVs)
were detected within the pelvic wall (Figure 2A). The
presence of germinal centers (BCL6) was detected inajp.amjpathol.org - The American Journal of Pathology
Table 4 Tertiary Lymphoid Structure Genes Were Enriched Following GO Pathways
GO no. Term Description Observed Gene Count Background Gene Count False Discovery Rate
0002376 Immune system process 198 1703 8.07  1089
0006955 Immune response 139 914 1.10  1071
0002682 Regulation of immune system process 139 1165 9.67  1060
0002684 Positive regulation of immune system process 104 771 1.79  1047
0001775 Cell activation 86 552 6.31  1043
0006952 Defense response 114 1079 6.31  1043
0045321 Leukocyte activation 80 464 1.15  1042
0050776 Regulation of immune response 89 635 2.09  1041
0050896 Response to stimulus 280 6616 3.33  1040
0046649 Lymphocyte activation 69 378 6.73  1038
0050778 Positive regulation of immune response 71 438 4.06  1036
0051249 Regulation of lymphocyte activation 68 396 6.63  1036
0002694 Regulation of leukocyte activation 71 479 6.15  1034
0050865 Regulation of cell activation 72 520 9.35  1033
0002250 Adaptive immune response 54 260 8.79  1032
0045087 Innate immune response 71 534 2.61  1031
0002252 Immune effector process 59 395 4.62  1028
0050863 Regulation of T cell activation 52 287 4.62  1028
1903037 Regulation of leukocyte cell-cell adhesion 50 264 9.52  1028
0032944 Regulation of mononuclear cell proliferation 46 217 2.90  1027
0006950 Response to stress 155 2899 4.47  1027
0048583 Regulation of response to stimulus 174 3552 6.66  1027
0050670 Regulation of lymphocyte proliferation 45 215 1.64  1026
0048584 Positive regulation of response to stimulus 122 1922 1.76  1026
0051707 Response to other organism 76 779 8.22  1026
0022407 Regulation of cell-cell adhesion 54 360 8.45  1026
1903039 Positive regulation of leukocyte cell-cell adhesion 42 190 1.50  1025
0050870 Positive regulation of T-cell activation 41 180 2.31  1025
0051251 Positive regulation of lymphocyte activation 46 253 6.07  1025
0009605 Response to external stimulus 113 1794 4.76  1024
0022409 Positive regulation of cell-cell adhesion 43 227 6.74  1024
0042110 T-cell activation 44 244 1.00  1023
0002253 Activation of immune response 42 221 2.18  1023
0030155 Regulation of cell adhesion 65 624 2.39  1023
0050867 Positive regulation of cell activation 48 314 3.13  1023
0002696 Positive regulation of leukocyte activation 47 300 3.88  1023
0050789 Regulation of biological process 308 9594 7.55  1023
0007165 Signal transduction 164 3594 7.24  1022
0051716 Cellular response to stimulus 205 5142 7.68  1022
0065007 Biological regulation 317 10,168 8.13  1022
0098542 Defense response to other organism 50 397 6.23  1021
0002520 Immune system development 64 687 1.20  1020
0002757 Immune responseeactivating signal transduction 35 168 1.46  1020
0002764 Immune responseeregulating signaling pathway 36 184 2.22  1020
0002521 Leukocyte differentiation 46 340 2.41  1020
0030098 Lymphocyte differentiation 40 243 2.55  1020
0048518 Positive regulation of biological process 206 5340 2.81  1020
0048534 Hematopoietic or lymphoid organ development 62 659 3.29  1020
0045785 Positive regulation of cell adhesion 48 383 4.89  1020
0002376 Immune system process 198 1703 8.07  1089
Data from http://geneontology.org/docs/go-enrichment-analysis, last accessed June 25, 2020.
GO, Gene Ontology.
Interconnected TLS in Lupus Nephritislarger TLS (Figure 2A). Mist and plasma cells were
detected within the TLS in areas outside the dense B-cell
zones and germinal centers (Figure 2C). In the large ag-
gregates, many small microvessels were detectedThe American Journal of Pathology - ajp.amjpathol.orgthroughout the structure, whereas HEVs were mostly
located along the pelvic wall (Figure 2D). Large lymphatic
vessel endothelial hyaluronan receptor 1epositive thin
vessels were identified and contained CD3þ and B220þ T2213
Table 5 Group 2 and 3 Expression Level of Tertiary Lymphoid Structure Genes Found in the Gene Ontology Term Hematopoietic or Lymphoid
Organ Development
Gene Target Description Base Mean
Group 1 vs
Group 2 Group 1 vs Group 3
Group 2 vs
Group 3
logFC PADJ logFC PADJ logFC PADJ
Apobec3 ENSMUSG00000009585 Apobec3, apolipoprotein B mRNA
editing enzyme, catalytic
polypeptide 3
232 NS 1.2 3.90  104 NS
B2m ENSMUSG00000060802 B2m, b2-microglobulin 10,905 NS 1.5 1.08  1012 NS
Batf ENSMUSG00000034266 Batf, basic leucine zipper
transcription factor, ATF-like
60 2.0 4.07  104 2.5 1.09  107 NS
Btk ENSMUSG00000031264 Btk, Bruton
agammaglobulinemia tyrosine
kinase
51 1.5 7.66  103 2.4 5.83  108 NS
Ccl19 ENSMUSG00000071005 Ccl19, chemokine (C-C motif)
ligand 19
75 2.5 1.07  104 NS 2.2 8.82  105
Ccr7 ENSMUSG00000037944 Ccr7, chemokine (C-C motif)
receptor 7
88 2.1 6.47  105 NS 1.2 1.14  102
Cd3d ENSMUSG00000032094 Cd3d, CD3 antigen, delta
polypeptide
97 2.8 6.14  107 1.8 4.37  104 NS




8325 NS 2.2 4.39  1024 1.3 9.44  104
Cd79a ENSMUSG00000040592 Cd79b, CD79B antigen 121 NS 1.9 1.06  102 NS
Cxcl13 ENSMUSG00000023078 Cxcl13, chemokine (C-X-C motif)
ligand 13
92 5.1 3.12  107 5.8 1.50  1010 NS
Dock2 ENSMUSG00000020143 Dock2, dedicator of cytokinesis 2 227 1.0 2.43  103 1.2 9.48  106 NS
H2ab1 ENSMUSG00000073421 H2-Ab1, histocompatibility 2,
class II antigen A, b1
837 NS 1.9 5.34  1010 1.1 6.67  104
H2-DMa ENSMUSG00000037649 H2-DMa, histocompatibility 2,
class II, locus DMa
296 NS 1.7 1.38  108 NS
Hcls1 ENSMUSG00000022831 Hcls1, hematopoietic cell
specific Lyn substrate 1
47 1.8 6.83  103 2.8 5.80  108 NS
Ikzf1 ENSMUSG00000018654 Ikzf1, IKAROS family zinc
finger 1
149 2.1 4.70  108 2.4 7.62  10-12 NS
Irf1 ENSMUSG00000018899 Irf1, interferon regulatory
factor 1
1130 NS 1.2 1.20  10-09 NS
Irf4 ENSMUSG00000021356 Irf4, interferon regulatory
factor 4
164 NS 1.9 5.55  10-03 NS
Lck ENSMUSG00000000409 Lck, lymphocyte protein
tyrosine kinase
66 2.5 5.56  105 2.5 2.76  10-06 NS
Lyn ENSMUSG00000042228 Lyn, Yamaguchi sarcoma viral
(v-yes-1) oncogene homolog
819 NS 1.5 3.78  10-11 NS
Nckap1l ENSMUSG00000022488 Nckap1l, NCK associated protein
1 like
589 1.6 7.84  106 2.3 3.68  10-14 NS
Pld4 ENSMUSG00000052160 Pld4, phospholipase D family,
member 4
417 1.5 1.80  103 3.0 8.18  10-15 1.5 2.56  104
Plek ENSMUSG00000020120 Plek, pleckstrin 270 2.8 3.23  104 3.7 2.10  108 NS
Pou2f2 ENSMUSG00000008496 Pou2f2, POU domain, class 2,
transcription factor 2
534 2.5 2.63  105 3.3 4.62  1010 NS
Ptpn22 ENSMUSG00000027843 Ptpn22, protein tyrosine
phosphatase, non-receptor
type 22 (lymphoid)
256 NS 1.0 6.43  104 NS
Ptprc ENSMUSG00000026395 Ptprc, protein tyrosine
phosphatase, receptor type, C
97 1.8 1.53  102 2.6 4.43  106 NS
Siglecg ENSMUSG00000030468 Siglecg, sialic acid binding Ig-
like lectin G
50 3.2 7.07  108 2.5 9.63  106 NS
(table continues)
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Table 5 (continued )
Gene Target Description Base Mean
Group 1 vs
Group 2 Group 1 vs Group 3
Group 2 vs
Group 3
logFC PADJ logFC PADJ logFC PADJ
Spn ENSMUSG00000051457 Spn, sialophorin 380 2.4 3.67  105 3.1 6.25  1010 NS
Syk ENSMUSG00000021457 Syk, spleen tyrosine kinase 84 1.2 4.41  102 1.9 1.05  105 NS
Tcf7 ENSMUSG00000000782 Tcf7, transcription factor 7, T
cell specific
93 1.9 1.65  104 1.6 3.18  104 NS
Tnfrsf13b ENSMUSG00000010142 Tnfrsf13b, tumor necrosis factor
receptor superfamily, member
13b
120 1.9 3.48  105 2.7 1.73  1011 NS
Tyrobp ENSMUSG00000030579 Tyrobp, TYRO protein tyrosine
kinase binding protein
330 NS 2.4 5.38  1010 1.6 6.41  105
Ubd ENSMUSG00000035186 Ubd, ubiquitin D 291 2.3 8.53  107 2.4 7.29  109 NS
Vav1 ENSMUSG00000034116 Vav1, vav 1 oncogene 220 1.5 3.39  104 2.3 7.42  1011 NS
Zfp36l2 ENSMUSG00000045817 Zfp36l2, zinc finger protein 36,
C3H type-like 2
182 NS NS 1.5 4.05  107
Data from https://www.ensembl.org/index.html, last accessed June 25, 2020.
logFC, log fold change; NS, not significant; PADJ, P adjusted.
Interconnected TLS in Lupus Nephritisand B cells, in addition to a few MIDC-8þ DCs
(Figure 2E). Previously obtained animals (n Z 493,5) were
analyzed for the presence of TLS, and a high correlation
between the anti-dsDNA antibody titer and development
of TLS was observed (Table 2). Even in mice negative for
anti-dsDNA antibody, small aggregates of CD3þ T cells
and F4/80þ macrophages could be observed within the
pelvic wall of the kidneys (Figure 2F).
Comparison of DE Genes in Isolated TLS, Kidney
Tissues, and Lymph Nodes Reveals Similarities between
Lymph Nodes and TLS
To investigate whether the TLS resembles lymph nodes
with respect to gene expression, total RNA was isolated
from renal draining lymph nodes, kidney, and TLS
dissected from kidney (n Z 3). The gene expression was
analyzed by the Ion Torrent PGM system, and 13,982
DE genes were identified in a comparison of genes be-
tween TLS and kidney, lymph nodes versus kidney, and
TLS versus lymph nodes (Supplemental Table S1).
Figure 3A shows a Venn diagram of the significantly DE
genes in the different comparisons (Supplemental Tables
S2eS4). Kidney versus TLS reveled 1071 DE genes,
where 371 genes were up-regulated in kidney and 644
genes were up-regulated in TLS (Figure 3, A and B, and
Supplemental Table S2), whereas kidney versus lymph
nodes had the most DE genes (Figure 3, A and B, and
Supplemental Table S3). Comparing the 644 genes up-
regulated in TLS with the genes significantly up-
regulated in lymph nodes compared with kidney
(Supplemental Table S3) revealed 600 common genes
(Figure 3C). Reactome pathway analyzer recognized 400The American Journal of Pathology - ajp.amjpathol.orgof these genes, and Table 3 lists the top 20 enriched
pathways. Search Tool for the Retrieval of Interacting
Genes/Proteins (STRING) functional enrichment analyses
recognized 455 genes found in gene ontology pathways
mostly involved in activation and regulation of the im-
mune system (Table 4). Of interest, 62 TLS genes were
found in the Gene Ontology term hematopoietic or
lymphoid organ development (Table 4). DE genes be-
tween TLS and lymph nodes defined the kidney-specific
genes found in isolated TLS (Figure 3B and
Supplemental Table S4).Gene Expression in Total Kidney Reflects Development
of TLS and Progression of LN
To investigate the gene expression profile during the
development of TLS within the kidneys of lupus-prone
mice during LN progression, RNA sequencing was per-
formed on whole kidneys isolated from three groups of
mice; young, antibody negative (group 1), 4 to 5 week
anti-dsDNA antibody-positive mice (group 2), and pro-
teinuric mice (group 3). Five mice in each group were
selected based on their age (7 weeks old), weeks of anti-
dsDNA antibody-positive serum samples (4 to 5 weeks),
and proteinuria (þ3 and þ4) and renamed (Table 1 and
Figure 1A). A two-dimensional scatterplot determining
the greatest sources of variation between samples with
approximations of log2-fold changes revealed that one
group 3 mouse (M13) clustered close to group 2 mice and
one group 2 mouse (M6) clustered close to group 1 mice
(Figure 4A). This finding was confirmed in a heatmap
presenting the top 30 variable (up- and down-regulated)


































































































































































































































































Group 3 Group 2Group 1
B cell activation
Integrin signaling
Figure 4 The gene expression analyses of total kidneys from the selected New Zealand black  New Zealand white (NZB/W) mice clustered into three
groups. A: Multidimensional scaling plot showing the relationship among all mice kidney samples (M1 to M15). Group 1 included 7-weekeold (M1 to
M5), group 2 included antibody positive (ABþ) mice (M6 to M10), and group 3 included proteinuric mice (M11 to M15). B: Heatmap of the 30 most
variable genes across all samples. The dendrogram shows a global relationship between samples and genes. The z score indicates whether the genes are
above or below the mean and by how many SDs. C: Real-time quantitative PCR of Ltb, Ltbr, Cxcl13, Ccr7, Aid (alias Aicda), Pou2af1, Rankl (alias Tnfsf11),
Glycam (Glycam1), Vcam1, and Icam1 gene expression analyzed on the cDNA from group 1 (young), group 2 (ABþ), and group 3 (proteinuric) mice.
*P < 0.05, **P < 0.01.
Dorraji et al
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Figure 5 Gene expression of total kidneys reflect development of tertiary lymphoid structures. Venn diagram of up-regulated (A) and down-regulated (B)
genes in group 1, 2, and 3 mice. Volcano plot depicting the gene expression in group 1 versus group 2 (C), group 1 versus group 3 (D), and group 2 versus
group 3 (E) comparisons. Group 1 (Gr1, alias G1), young, antibody negative mice; group 2 (Gr2, alias G2), 4 to 5 week anti-dsDNA antibody-positive mice;
group 3 (Gr3, alias G3), proteinuric mice.
Interconnected TLS in Lupus Nephritisclustered into three distinct branches (Figure 4B).
Most of these genes are involved in the immune system
and specifically to integrin signaling and B-cell activa-
tion. Of interest, among the highly variable genes are
genes associated with the formation of TLS [Ighg1,
Ighg2, Igj (Jchain), Ighm, Igha, Ighg3, Iglc2, Igkc,
Pou2af1].
A selection of genes important for TLS induction were
analyzed by real-time quantitative PCR. The genes Ltb,
Cxcl13, Aid (alias Aicda), Pou2af1, Rankl (alias Tnfsf11),
and Glycam (alias Glycam1) were significantly up-regulated
in group 2 mice compared with group 1 mice (Figure 4C).
The genes Ltbr, Ccr7, Pou2af1, Glycam, Vcam1, and Icam1
were significantly up-regulated in group 3 mice (Figure 4C).
The expression of these genes were positively correlated to
anti-dsDNA antibody production and TLS formation
(Table 2).The American Journal of Pathology - ajp.amjpathol.orgThe genes found in TLS and lymph nodes were further
compared with the DE genes in group 2 and 3 mice
compared with group 1 mice (Figure 5, A and B, and
Supplemental Tables S5eS7). Most of the DE genes
observed in groups 2 and 3 were immune system related
(Figure 5, CeE). Of the 644 genes found DE in TLS, 133
were found in group 2 mice, and 201 were found in group
3 mice (Figure 6A and Supplemental Table S8). In addi-
tion, 52 and 186 lymph nodes genes were found in group 2
and 3 mice, respectively (Figure 6A and Supplemental
Table S8). Thirty-four of these genes were found in the
Gene Ontology term hematopoietic or lymphoid organ
development (0048534). Table 5 lists the expression level
in all comparisons. Protein-protein interaction networks
analyses using STRING of the 130 common genes found
in groups 2 and 3, and TLS had a strong T- and B-cell
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Interconnected TLS in Lupus Nephritisexpression (all genes >0.5) in group 1 and 3 NZB/W mice
and the DE genes in group 2 and 3 mice with published
gene expression in kidneys of 8-weekeold male C57BL/6J
mice (n Z 3)29 revealed 182 to 189 common genes
(Supplemental Figure S1 and Supplemental Tables
S9eS11). A large proportion of these were immune
systemerelated genes.
To analyze whether the gene expression of TLS in kid-
neys was similar to gene expression of TLS observed in
another mouse strain, the published data on TLS were
compared within the chorus plexus of MRL lpr/lpr mice.30
The DE genes of chorus plexus TLS had 421 common
genes with kidney TLS, 213 common genes with DE genes
in group 2 mice, and 436 common genes compared with DE
genes in group 3 mice (Figure 6C and Supplemental Table
S12). The comparison found 126 common genes within all
groups, and paired correlation plots on scaled log2-fold
change of the genes revealed some of these (Figure 6D).
Murine Expression Profiles Comparable to Human LN
Gene Expression
It was investigated whether the gene expression observed in
murine kidneys, isolated TLS, and lymph nodes could be
comparable to a recent published gene expression profile
observed in human kidney biopsies from patients with SLE
and LN31 and single-cell sequencing of immune cell profiles
in similar patients with LN.32 Of the 414 human DE genes in
patients with SLE compared with normal human kidney
samples, 65 were found expressed in murine kidney TLS
(Figure 6, E and F, and Supplemental Tables S13 and S14).
Of these genes, 24 were found in group 2 mice, and 39 were
found in group 3 mice. STRING interaction network analyses
of the 65 genes were analyzed with the human and murine
genes, revealing a similar interaction network, although with
some differences (Figure 7). In addition to the genes found in
TLS, 7 and 45 human genes were also found in group 2 and 3
mice, respectively (Figure 6, E and F). These genes were
enriched in several biological processes (Table 6). Compar-
ison of the gene expression in TLS and group 3 mice with the
cell-specific gene clusters of T-regulatory cells (Tregs) and
follicular T-helper (TFH) cells found in human patients with
SLE revealed 133 Treg genes and 125 TFH genes in TLS
(Figure 8A and Supplemental Table S15). In group 3 mice,Figure 6 Tertiary lymphoid structure (TLS)-related genes are up-regulated in m
gene expression compared with gene expression in TLS and lymph nodes (LyN).
network of the 133 common genes showing the molecular action with the minimum
nodes are not shown. Action types are as follows: green, activation; red, inhibitio
black, reaction. Action effects are as follows: arrow indicates positive; red lin
differentially expressed (DE) genes in New Zealand black  New Zealand white (NZ
1 (nZ 259), DE up-regulated genes in group 3 versus group 1 (nZ 973), and the
D: Paired correlation plots on scaled log2 fold change values of the 126 common
compared with DE genes in group 2 mice compared with group 1 (nZ 285), TLS (n
414 human genes compared with DE genes in group 3 mice compared with group 1
(G1), young, antibody negative mice; group 2 (G2), 4 to 5 week anti-dsDNA ant
The American Journal of Pathology - ajp.amjpathol.org223 Treg genes and 160 TFH genes were found up-regulated
(Figure 8A). The Tregs were quantified using immunohisto-
chemistry and immunofluorescence-stained kidney sections.
The number of Tregs increased in the cortex and medulla
during the development of LN (Figure 8B). In the young
mice, the Tregs were located within the pelvic wall close to
the largest arteries and veins (Figure 8C), whereas in the older
mice, the Tregs were increasingly found in the circulation
within the glomeruli and tubuli interstitially. However, most
Tregs were located within the TLS (Figure 8D). Analysis of
all the single-cell profiles of immune cells found in human
LN with the gene profile of murine TLS identified almost all
genes differentially expressed in murine kidneys during LN
development (data not shown).Discussion
Aggregates of lymphocytes resembling TLS have been
described within the kidney of both human and murine
LN.15,33e35 The development of fully functional and orga-
nized TLS has not previously been reported for the NZB/W
mouse model. In this study, the formation of large TLS
within the pelvic wall of the medulla and close to the arcuate
arteries within the cortex of kidneys taken from lupus-prone
NZB/W mice were found. The structures were organized in
large, interconnected areas along the veins and arteries. It was
found that the structures contain all cells necessary to func-
tion as an activation site or a site for regulating T and B cells.
The gene expression of TLS and the change in gene
expression within the kidney during the development of
LN resembled the gene expression in lymph nodes. Most
of the up-regulated genes in the kidney were involved in
the innate and adaptive immune system, whereas the
down-regulated genes were mostly involved in metabolic
processes. This finding agrees with previous studies on
both human LN biopsies and other murine lupus
models.36,37 Indeed, when the gene expression profile of
TLS, lymph nodes, and group 2 and 3 mice were
compared with the published gene expression profile of
kidney biopsies from patients with SLE and LN, some of
the genes were common.31 Among these genes, C1q,
Ptpn22, and Tnfsf13b (BAFF) are involved in the
development of LN.38e40urine and human lupus nephritis kidneys. A: Venn diagram of group 2 and 3
B: Search Tool for the Retrieval of Interacting Genes/Proteins interaction
required interaction score of highest confidence (0.900). The disconnected
n; blue, binding; purple, catalyst; pink, posttranslational modification; and
e, negative; dot, unspecified. C: Venn diagram showing the number of
B/W) kidney TLS (n Z 644), DE up-regulated genes in group 2 versus group
1485 up-regulated genes found in the chorus plexus TLS of MRL lpr/lpr mice.
genes found in panel C. E: Venn diagram showing the 414 human genes
Z 644), and lymph nodes genes (nZ 1976). F: Venn diagram showing the
(n Z 1436), TLS (n Z 644), and lymph nodes genes (n Z 1976). Group 1





Murine Figure 7 Search Tool for the Retrieval of Interacting
Genes/Proteins interaction network of the 65 Tertiary
lymphoid structure genes found in human lupus nephritis
(LN) gene expression analyses. The genes were analyzed
as human (A) or murine (B) genes.
Dorraji et alIn addition to the strong gene signature of immuno-
globulins, an early activation of T cells and natural
killer cells in group 2 mice were identified. It has been
previously reported that T cells are infiltrating the2220kidneys at an early stage.5,22 Many of the genes seen
up-regulated in group 2 mice are involved in tran-
scriptional and epigenetic regulation of TFH cells.41

















































































Figure 8 Infiltrating T-regulatory cells (Tregs) are detected within the pelvic wall and increase in both cortex and medulla during the development of lupus
nephritis (LN). A: Venn diagram of tertiary lymphoid structure (TLS)especific gene compared with genes found in human kidney infiltrating Tregs and follicular
T-helper (TFH) cells and group 3 mice. The gene expression after single-cell sequencing cluster profiling of kidney infiltrating Tregs (n Z 1990) and TFH cells
(n Z 1523) in LN were compared to the TLS-specific genes (n Z 644) and the up-regulated genes in group 3 mice (n Z 973). B: Forkhead box P3 (FoxP3)e
positive cells were counted in 10 view fields at 20 magnification within the cortex and the whole medulla/TLS of 4- to 8-weekeold, 10- to 18-weekeold,
antiedouble-stranded DNA antibodyepositive (Abþ), and proteinuric (Prot) New Zealand black  New Zealand white (NZB/W) mice. FoxP3-positive cells
increase in the cortex and medulla of mice in the Prot group. C and D: CD3-positive (top rows, brown cells and black arrows) and FoxP3 positive-cells (bottom
rows, white arrows and pink cells) detected within the pelvic wall of young NZB/W mice (C) and Abþ and Prot NZB/W mice (D). *P < 0.05. Scale bars: 50 mm
(C, and D, left column); 20 mm (D, right column). a, artery; pw, pelvic wall; v, vein.
Interconnected TLS in Lupus Nephritisgerminal centers.42 Together with the expression of
various immunoglobulin genes and the composition of
B cells, FDCs, and TFH cells, this finding indicates that
the TLS may have functional germinal centers that may
be involved in the disease development. The local
production of kidney-specific autoantibodies may trans-
fer the disease from a silent nephritis to a clinical active
disease. However, the gene expression profiles also
indicate that the TLS may have a regulatory effect.
FoxP3 Tregs were found in the cortex and medulla in
addition to the TLS, increasing with disease progres-
sion. Tregs in SLE have been extensively studied, but
they reveal a large heterogeneity and the results areThe American Journal of Pathology - ajp.amjpathol.orgcontradictory.43 However, evidence indicates that an
increased amount of Tregs are found in patients with
SLE,42 especially within the kidneys of patients with
LN.44,45 Interestingly, in recently published data, a
unique thymus-derived Treg population was found to be
increased in patients with SLE.46 Hanaoka et al46 also
found infiltration of these Tregs within kidney biopsies
from patients with active LN. The results from our
comparison to the human single-cell gene expression
data indicated a similar finding. In a study on kidney
infiltrating T cells in MRL lpr mice, an exhausted
phenotype was found,47 which could be caused by
regulation (Treg) in TLS and thereby have an inhibitory2221
Table 6 Genes Up-Regulated in Human LN and Murine LN Not Found in TLS or Lymph Nodes Were Enriched Following GO Terms








Rate Matching Proteins in the Network (Labels)
0030198 Extracellular matrix
organization




4 39 0.0014 COL1A1,COL1A2,COL3A1,LUM
0034097 Response to cytokine 12 1035 0.0014 ALDH1A2,ANXA1,AXL,CCR5,COL1A1,COL1A2,COL3A1,
CXCL10,IFIT1,IFIT2,OAS2,XAF1
0071229 Cellular response to
acid chemical
6 196 0.0020 ALDH1A2,COL1A1,COL1A2,COL3A1,PTGER4,TNC
0001501 Skeletal system
development




6 210 0.0024 COL1A1,COL3A1,CXCL10,PTGER4,SERPINE2,TNC
0042060 Wound healing 8 461 0.0024 ANXA1,AXL,COL1A1,COL1A2,COL3A1,MYOF,
SERPINE2,TNC
0071396 Cellular response to
lipid
8 486 0.0025 ALDH1A2,ANXA1,AXL,CCR5,COL1A1,
CXCL10,PTGER4,TNC
0060337 Type I interferon
signaling pathway
4 65 0.0029 IFIT1,IFIT2,OAS2,XAF1
1901701 Cellular response to
oxygen-containing
compound




16 2370 0.0045 ANXA1,AP1S2,AXL,CCR5,CFH,COL1A1,COL1A2,
CXCL10,FGL2,IFIT1,IFIT2,OAS2,PTGER4,
PXDN,RUNX1,XAF1
0009605 Response to external
stimulus
14 1857 0.0046 ALDH1A2,ANXA1,AXL,CCR5,CMTM3,COL1A1,
COL3A1,CXCL10,
IFIT1,IFIT2,OAS2,PTGER4,SERPINE2,TNC
0071345 Cellular response to
cytokine stimulus
10 953 0.0047 ANXA1,AXL,CCR5,COL1A1,COL1A2,
CXCL10,IFIT1,IFIT2,OAS2,XAF1
0033273 Response to vitamin 4 87 0.0048 ALDH1A2,COL1A1,CXCL10,TNC
0071310 Cellular response to
organic substance




0097350 Neutrophil clearance 2 5 0.0079 ANXA1,AXL




8 655 0.0080 ANXA1,CCR5,COL1A2,CXCL10,IFIT1,
IFIT2,OAS2,XAF1
0006955 Immune response 12 1560 0.0096 ANXA1,AXL,CCR5,CFH,CXCL10,FGL2,
IFIT1,IFIT2,OAS2,
PTGER4,PXDN,XAF1
0070848 Response to growth
factor
7 507 0.0096 ANXA1,COL1A1,COL1A2,COL3A1,LUM,RGMB,TNC
Data from http://geneontology.org/docs/go-enrichment-analysis, last accessed June 25, 2020.
GO, Gene Ontology; LN, lupus nephritis; TLS, tertiary lymphoid structures.
Dorraji et aleffect on T cells. However, in a recently published
article on single-cell sequencing of immune cells iso-
lated from kidney biopsies of patients with LN, the
authors did not find this exhausted phenotype.32 They
found a subset of regulatory cells, particularly TFH
regulatory cells, indicating that more studies on the role
of TLS in kidney diseases are needed.2222The role of macrophages, DCs, and B cells in the pro-
gression of LN has been extensively studied in humans and
mice.48,49 In studies using DC depletion and DC plus B-
cell Myd88 deletion, perivascular and peritubular in-
filtrates were decreased in DC-depleted and Myd88-
deleted lupus-prone animals compared with sick control
mice.49,50 Nevertheless, the fact that the peritubularajp.amjpathol.org - The American Journal of Pathology
Interconnected TLS in Lupus Nephritisinfiltrates were diminished but still present indicates a role
for cells other than DCs and B cells in the induction of
TLS. This assumption was confirmed because B cells and
DCs were not found in the early aggregates that consisted
of mainly macrophages, T cells, and intrinsic kidney cells.
The gene expression analyses found an increased expres-
sion of monocyte and macrophage-related genes to be up-
regulated during the progression of the disease. A study by
Schiffer et al48 found that macrophages are one of the first
immune cells to be activated and increased in the devel-
opment of LN. They also found that the effect of inter-
feron-a not only activates the innate immune system but
that the anti-dsDNA antibody induction and clinical SLE
driven by interferon-a are dependent on CD4þ T cells.51
The activation and infiltration of T cells within the kid-
ney and the formation of TLS need to be further studied to
determine whether TLS have an active role in driving the
disease from a silent to a clinical active disease or whether
TLS may have an inhibitory effect on the disease
progression.
The current study results are in line with and extend
previous results because structures that resembled TLS in
the cortex of human kidney biopsies taken from patients
with SLE and LN were associated with tubular basement
membrane immune complexes.12 Clark et al12 described
three patterns of tubulointerstitial infiltrates in the kid-
neys of patients with SLE, starting from diffuse scattered,
lymphocytic infiltration and continuing through T/B ag-
gregates to germinal centers (characterized by the spatial
cellular organization and FDCs). The germinal centers
were found for only 6% of the biopsies analyzed. In a
retrospective study on kidney biopsies from patients with
IgA nephropathies, a strong association with TLS for-
mation and the severity of disease was found.11 Patients
with high-grade TLS exhibited a higher percentage of
mesangial hypercellularity and crescents as well as severe
interstitial and arterial lesions.11 In the current study’s
findings in kidneys of lupus-prone mice, the same pat-
terns could be observed, often within the same kidney,
and sometimes interconnected to larger structures in the
hilum. Given that the human kidney biopsies are mainly
taken from the cortical region of the kidneys, it is inter-
esting that huge aggregates within the pelvic area of the
kidney can be observed. We hypothesize that the kidney
of patients with SLE may develop the same large struc-
tures because we observed similar patterns of immune
cells within the cortex of murine kidneys as within
human LN biopsies. However, the discovery of large TLS
in human kidneys is unlikely with current methods
because the detection of these structures is dependent on
kidney biopsies. Developing new in vivo imaging
methods, such as positron emission tomography/magnetic
resonance imaging, to detect these structures at an early
phase may lead to early diagnosis and better treatment
strategies.The American Journal of Pathology - ajp.amjpathol.orgAuthor Contributions
P.K., C.F., K.D.H. and K.A.F. designed the study; S.E.D,
P.K., A.M.K.H., K.D.H., A.U., D.T., and K.A.F. per-
formed experiments; S.E.D., P.K., A.M.K.H., S.L.F., C.F.,
H.L.P., and K.A.F. analyzed the data; S.E.D., C.F., and
K.A.F. made the figures; S.E.D., P.K., A.M.K.H., K.D.H.,
A.U., D.T., S.L.F., C.F., H.L.P., and K.A.F. drafted and
revised the manuscript; all authors approved the final
version of the manuscript. K.A.F. is the guarantor of this
work and, as such, had full access to all the data in the
study and takes responsibility for the integrity of the data
and the accuracy of the data analysis.Supplemental Data
Supplemental material for this article can be found at
http://doi.org/10.1016/j.ajpath.2020.07.015.References
1. Rekvig OP, Thiyagarajan D, Pedersen HL, Horvei KD, Seredkina N:
Future perspectives on pathogenesis of lupus nephritis: facts, prob-
lems, and potential causal therapy modalities. Am J Pathol 2016, 186:
2772e2782
2. Seredkina N, van der Vlag J, Berden J, Mortensen E, Rekvig OP:
Lupus nephritis - enigmas, conflicting models and an emerging
concept. Mol Med 2013, 19:161e169
3. Fenton K, Fismen S, Hedberg A, Seredkina N, Fenton C, Mortensen ES,
Rekvig OP: Anti-dsDNA antibodies promote initiation, and acquired
loss of renal Dnase1 promotes progression of lupus nephritis in auto-
immune (NZBNZW)F1 mice. PLoS One 2009, 4:e8474
4. Kalaaji M, Fenton KA, Mortensen ES, Olsen R, Sturfelt G, Alm P,
Rekvig OP: Glomerular apoptotic nucleosomes are central target
structures for nephritogenic antibodies in human SLE nephritis.
Kidney Int 2007, 71:664e672
5. Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA: Nucleo-
somes contribute to increase mesangial cell chemokine expression
during the development of lupus nephritis. Cytokine 2013, 62:
244e252
6. Yung S, Cheung KF, Zhang Q, Chan TM: Mediators of inflammation
and their effect on resident renal cells: implications in lupus nephritis.
Clin Dev Immunol 2013, 2013:317682
7. Maria NI, Davidson A: Renal macrophages and dendritic cells in SLE
nephritis. Curr Rheumatol Rep 2017, 19:81
8. Tsokos GC, Lo MS, Costa RP, Sullivan KE: New insights into the
immunopathogenesis of systemic lupus erythematosus. Nat Rev
Rheumatol 2016, 12:716e730
9. Aloisi F, Pujol-Borrell R: Lymphoid neogenesis in chronic inflam-
matory diseases. Nat Rev Immunol 2006, 6:205e217
10. van de Pavert SA, Mebius RE: New insights into the development of
lymphoid tissues. Nat Rev Immunol 2010, 10:664e674
11. Pei G, Zeng R, Han M, Liao P, Zhou X, Li Y, Zhang Y, Liu P,
Zhang C, Liu X, Yao Y, Xu G: Renal interstitial infiltration and
tertiary lymphoid organ neogenesis in IgA nephropathy. Clin J Am
Soc Nephrol 2014, 9:255e264
12. Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C,
Kaverina N, Utset TO,Meehan SM, Quigg RJ, Meffre E, ClarkMR: In
situ B cell-mediated immune responses and tubulointerstitial inflam-
mation in human lupus nephritis. J Immunol 2011, 186:1849e18602223
Dorraji et al13. He N, Chen WL, Long KX, Zhang X, Dong GF: Association of
serum CXCL13 with intrarenal ectopic lymphoid tissue formation in
lupus nephritis. J Immunol Res 2016, 2016:4832543
14. Kelly FM, Reddy RN, Roberts BR, Gangappa S, Williams IR,
Gooch JL: TGF-beta upregulation drives tertiary lymphoid organ
formation and kidney dysfunction in calcineurin A-alpha heterozy-
gous mice. Am J Physiol Renal Physiol 2009, 296:F512eF520
15. Kang S, Fedoriw Y, Brenneman EK, Truong YK, Kikly K, Vilen BJ:
BAFF induces tertiary lymphoid structures and positions T cells
within the glomeruli during lupus nephritis. J Immunol 2017, 198:
2602e2611
16. Huang Y, Caputo CR, Noordmans GA, Yazdani S, Monteiro LH,
van den Born J, van Goor H, Heeringa P, Korstanje R,
Hillebrands JL: Identification of novel genes associated with renal
tertiary lymphoid organ formation in aging mice. PLoS One 2014,
9:e91850
17. Sato Y, Mii A, Hamazaki Y, Fujita H, Nakata H, Masuda K,
Nishiyama S, Shibuya S, Haga H, Ogawa O, Shimizu A, Narumiya S,
Kaisho T, Arita M, Yanagisawa M, Miyasaka M, Sharma K,
Minato N, Kawamoto H, Yanagita M: Heterogeneous fibroblasts
underlie age-dependent tertiary lymphoid tissues in the kidney. JCI
Insight 2016, 1:e87680
18. Bethunaickan R, Berthier CC, Zhang W, Kretzler M, Davidson A:
Comparative transcriptional profiling of 3 murine models of SLE
nephritis reveals both unique and shared regulatory networks. PLoS
One 2013, 8:e77489
19. Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V,
Ramanujam M, Zhang W, Bottinger EP, Segerer S, Lindenmeyer M,
Cohen CD, Davidson A, Kretzler M: Cross-species transcriptional
network analysis defines shared inflammatory responses in murine
and human lupus nephritis. J Immunol 2012, 189:988e1001
20. Berthier CC, Kretzler M, Davidson A: A systems approach to renal
inflammation in SLE. Clin Immunol 2017, 185:109e118
21. Berthier CC, Kretzler M, Davidson A: From the large scale expres-
sion analysis of lupus nephritis to targeted molecular medicine. J Data
Mining Genomics Proteomics 2012, 3:1000123
22. Dorraji SE, Hovd AK, Kanapathippillai P, Bakland G, Eilertsen GO,
Figenschau SL, Fenton KA: Mesenchymal stem cells and T cells in
the formation of tertiary lymphoid structures in lupus nephritis. Sci
Rep 2018, 8:7861
23. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP: Critical
comparative analyses of anti-alpha-actinin and glomerulus-bound
antibodies in human and murine lupus nephritis. Arthritis Rheum
2006, 54:914e926
24. Rekvig OP, Moens U, Sundsfjord A, Bredholt G, Osei A,
Haaheim H, Traavik T, Arnesen E, Haga HJ: Experimental expres-
sion in mice and spontaneous expression in human SLE of poly-
omavirus T-antigen: a molecular basis for induction of antibodies to
DNA and eukaryotic transcription factors. J Clin Invest 1997, 99:
2045e2054
25. Tillman DM, Jou NT, Hill RJ, Marion TN: Both IgM and IgG anti-
DNA antibodies are the products of clonally selective B cell
stimulation in (NZB  NZW)F1 mice. J Exp Med 1992, 176:
761e779
26. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-
Goldman R, et al: 2019 European League Against Rheumatism/A-
merican College of Rheumatology classification criteria for systemic
lupus erythematosus. Arthritis Rheumatol 2019, 71:1400e1412
27. Robinson MD, Oshlack A: A scaling normalization method for dif-
ferential expression analysis of RNA-seq data. Genome Biol 2010,
11:R25
28. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor
package for differential expression analysis of digital gene expression
data. Bioinformatics 2010, 26:139e140
29. Clark JZ, Chen L, Chou CL, Jung HJ, Lee JW, Knepper MA: Rep-
resentation and relative abundance of cell-type selective markers in
whole-kidney RNA-Seq data. Kidney Int 2019, 95:787e796222430. Stock AD, Der E, Gelb S, Huang M, Weidenheim K, Ben-Zvi A,
Putterman C: Tertiary lymphoid structures in the choroid plexus in
neuropsychiatric lupus. JCI Insight 2019, 4:e124203
31. Pamfil C, Makowska Z, De Groof A, Tilman G, Babaei S, Galant C,
Montigny P, Demoulin N, Jadoul M, Aydin S, Lesche R,
McDonald F, Houssiau FA, Lauwerys BR: Intrarenal activation of
adaptive immune effectors is associated with tubular damage and
impaired renal function in lupus nephritis. Ann Rheum Dis 2018, 77:
1782e1789
32. Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al:
Accelerating medicines partnership in SLEn: the immune cell land-
scape in kidneys of patients with lupus nephritis. Nat Immunol 2019,
20:902e914
33. Adalid-Peralta L, Mathian A, Tran T, Delbos L, Durand-Gasselin I,
Berrebi D, Peuchmaur M, Couderc J, Emilie D, Koutouzov S: Leu-
kocytes and the kidney contribute to interstitial inflammation in lupus
nephritis. Kidney Int 2008, 73:172e180
34. Davidson A, Aranow C: Lupus nephritis: lessons from murine
models. Nat Rev Rheumatol 2010, 6:13e20
35. Shen Y, Sun CY, Wu FX, Chen Y, Dai M, Yan YC, Yang CD:
Association of intrarenal B-cell infiltrates with clinical outcome in
lupus nephritis: a study of 192 cases. Clin Dev Immunol 2012, 2012:
967584
36. Rai G, Rai R, Saeidian AH, Rai M: Microarray to deep sequencing:
transcriptome and miRNA profiling to elucidate molecular path-
ways in systemic lupus erythematosus. Immunol Res 2016, 64:
14e24
37. Gardet A, Chou WC, Reynolds TL, Velez DB, Fu K,
Czerkowicz JM, Bajko J, Ranger AM, Allaire N, Kerns HM, Ryan S,
Legault HM, Dunstan RW, Lafyatis R, Lukashev M, Viney JL,
Browning JL, Rabah D: Pristane-accelerated autoimmune disease in
(SWR X NZB) F1 mice leads to prominent tubulointerstitial
inflammation and human lupus nephritis-like fibrosis. PLoS One
2016, 11:e0164423
38. O’Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC,
Mathieson PW, van KC, van der Vlag J, Berden JH, Daha MR:
Nucleosomes and C1q bound to glomerular endothelial cells serve as
targets for autoantibodies and determine complement activation. Mol
Immunol 2011, 49:75e83
39. Mohan C, Putterman C: Genetics and pathogenesis of systemic lupus
erythematosus and lupus nephritis. NatRevNephrol 2015, 11:329e341
40. Collison J: Lupus nephritis: novel role for BAFF in tertiary lymphoid
neogenesis. Nat Rev Rheumatol 2017, 13:260
41. Qiu H, Wu H, Chan V, Lau CS, Lu Q: Transcriptional and epigenetic
regulation of follicular T-helper cells and their role in autoimmunity.
Autoimmunity 2017, 50:71e81
42. Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL,
Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG: Follicular
helper T cells are required for systemic autoimmunity. J Exp Med
2009, 206:561e576
43. Li W, Deng C, Yang H, Wang G: The regulatory T cell in active
systemic lupus erythematosus patients: a systemic review and meta-
analysis. Front Immunol 2019, 10:159
44. Ferreira RC, Castro Dopico X, Oliveira JJ, Rainbow DB, Yang JH,
Trzupek D, Todd SA, McNeill M, Steri M, Orru V, Fiorillo E,
Crouch DJM, Pekalski ML, Cucca F, Tree TI, Vyse TJ, Wicker LS,
Todd JA: Chronic immune activation in systemic lupus erythemato-
sus and the autoimmune PTPN22 Trp(620) risk allele drive the
expansion of FOXP3(þ) regulatory T cells and PD-1 expression.
Front Immunol 2019, 10:2606
45. Shakweer MM, Behairy M, Elhefnawy NG, Elsaid TW: Value of
Foxp3 expressing T-regulatory cells in renal tissue in lupus
nephritis; an immunohistochemical study. J Nephropathol 2016, 5:
105e110
46. Hanaoka H, Nishimoto T, Okazaki Y, Takeuchi T, Kuwana M: A
unique thymus-derived regulatory T cell subset associated with sys-
temic lupus erythematosus. Arthritis Res Ther 2020, 22:88ajp.amjpathol.org - The American Journal of Pathology
Interconnected TLS in Lupus Nephritis47. Tilstra JS, Avery L, Menk AV, Gordon RA, Smita S, Kane LP,
Chikina M, Delgoffe GM, Shlomchik MJ: Kidney-infiltrating T cells
in murine lupus nephritis are metabolically and functionally
exhausted. J Clin Invest 2018, 128:4884e4897
48. Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M,
Tao H, Madaio MP, Bottinger EP, Davidson A: Activated renal
macrophages are markers of disease onset and disease remission in
lupus nephritis. J Immunol 2008, 180:1938e1947
49. Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH,
ShlomchikMJ:Dendritic cells in lupus are not required for activation ofThe American Journal of Pathology - ajp.amjpathol.orgT and B cells but promote their expansion, resulting in tissue damage.
Immunity 2010, 33:967e978
50. Teichmann LL, Schenten D, Medzhitov R, Kashgarian M,
Shlomchik MJ: Signals via the adaptor MyD88 in B cells and DCs
make distinct and synergistic contributions to immune activation and
tissue damage in lupus. Immunity 2013, 38:528e540
51. Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP,
Davidson A: Interferon-alpha accelerates murine systemic lupus er-
ythematosus in a T cell-dependent manner. Arthritis Rheum 2011, 63:
219e2292225
